| Literature DB >> 30563287 |
Katarzyna Owczarek1, Błażej Kudłak2, Vasil Simeonov3, Zofia Mazerska4, Jacek Namieśnik5.
Abstract
Bisphenol A (BPA) is one of the most popular and commonly used plasticizer in the industry. Over the past decade, new chemicals that belong to the bisphenol group have increasingly been used in industrial applications as alternatives to BPA. Nevertheless, information on the combined effects of bisphenol (BP) analogues is insufficient. Therefore, our current study aimed to find the biological response modulations induced by the binary mixtures of BP compounds. We determined the toxicity levels in Microtox and XenoScreen YES/YAS assays for several BP analogs alone, and for their binary mixtures. The results obtained constituted the database for chemometric intelligent data analysis to evaluate the possible interactions occurring in the mixtures. Several chemometric/biophysical models have been used (concentration addition-CA, independent action-IA and polynomial regression calculations) to realize this aim. The best fitting was found for the IA model and even in this description strong evidence for synergistic behaviors (modes of action) of some bisphenol analogue mixtures was demonstrated. Bisphenols A, S, F and FL were proven to be of significant endocrine threat (with respect to XenoScreen YES/YAS assay); thus, their presence in mixtures (including presence in tissues of living organisms) should be most strictly monitored and reported.Entities:
Keywords: Microtox®; XenoScreen YES/YAS; bisphenol A analogues; model deviation ratio
Mesh:
Substances:
Year: 2018 PMID: 30563287 PMCID: PMC6321295 DOI: 10.3390/molecules23123226
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Concentration levels of bisphenol analogues studied during the research and EC50 values calculated for respective compounds.
| Analyte | Microtox® * | XenoScreen YES/YAS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Concentration Ranges Tested | EC50 ± SD ( | C1 | C2 | C3 | Concentration Ranges Tested | Effect ( | ||||
| [µM] | [µM] | |||||||||
| YES+ | YES− | YAS+ | YAS− | |||||||
| BPA | 8.96–71.68 | 37.7 ± 6.7 | 12.44 | 24.88 | 37.69 | 1.71–1752.15 | 173.9 L | >1752 N | >1752 N | >1752 N |
| BPC | 6.33–63.84 | 30.8 ± 2.1 | 10.17 | 20.34 | 30.82 | 1.53–1560.43 | 15.4 L | >1560 N | >1560 N | >1560 N |
| BPE | 38.19–305.49 | 57.9 ± 4.4 | 19.12 | 38.24 | 57.94 | 1.83–1866.89 | >1886 N | 1.83 L | >1886 N | 1.83 L |
| BPF | 10.22–81.72 | 28.3 ± 1.5 | 9.34 | 18.68 | 28.31 | 1.95–1997.70 | >1997 N | >1997 N | >1997 N | >1997 N |
| BPG | 2.60–26.19 | 14.85 ± 0.98 | 4.90 | 9.80 | 14.85 | 1.25–1280.21 | >1280 N | >1280 N | >1280 N | 12.6 L |
| BPM | 70.84–566.77 | >566.77 # | - | - | - | 1.13–1154.53 | >1154 N | >1154 N | >1154 N | 11.5 L |
| BPP | 70.84–566.77 | >566.77 # | - | - | - | 1.13–1154.53 | >1154 N | >1154 N | >1154 N | >1154 N |
| BPS | 32.69–261.54 | 61.6 ± 5.6 | 20.34 | 40.68 | 61.64 | 1.56–1598.27 | >1598 N | >1598 N | >1598 N | >1598 N |
| BPZ | 75.62–762.23 | >762.23 # | - | - | - | 1.46–1490.60 | >1490 N | >1490 N | >1490 N | >1490 N |
| BPFL | 0.58–58.40 | 3.31 ± 0.52 | 1.09 | 2.18 | 3.31 | 1.12–1141.52 | 1141.5 L | 113.3 L | 1141.5 L | >1141 N |
* C1, C2 and C3 stand for 33, 66 and 100% of EC50 of respective analyte. # solubility limit reached under conditions of the experiment, L LOEC, N NOEC.
Percentile values for model deviation ratios (MDR) and numbers of cases for each group of CA and IA experiments of BP toxicity studies.
| Model | No. of Cases | |||||||
|---|---|---|---|---|---|---|---|---|
| Synergism | Under-estimation | Over-estimation | Antagonism | Percentile | ||||
| 80 | 90 | 95 | 99 | |||||
| CA | 45 | 78 | 1 | 0 | 0.464 | 0.338 | 0.170 | 0.075 |
| IA | 5 | 4 | 8 | 3 | 0.860 | 0.780 | 0.720 | 0.396 |
MDR values for bisphenol A analogues binary mixtures toxicity studies performed with Microtox® assay (for both CA modelling) (red—Synergism, blue—Antagonism, green—Overestimation, yellow—Underestimation, C1, C2 and C3 stand for 33, 66 and 100% of EC50 of respective analogue as presented in Table 1. #—data inconclusive).
|
| |||||||||||||||||||
| BPA | |||||||||||||||||||
| C1 | C2 | C3 | |||||||||||||||||
| C1 | BPC | 0.76 | 0.71 | 0.74 | |||||||||||||||
| C2 | 0.79 | 0.79 | 0.75 | BPC | |||||||||||||||
| C3 | 0.90 | 0.81 | 0.59 | C1 | C2 | C3 | |||||||||||||
| C1 | BPE | 0.28 | 0.30 | 0.30 | 0.60 | 0.64 | 0.63 | ||||||||||||
| C2 | 0.74 | 0.65 | 0.77 | 0.84 | 0.71 | 0.58 | BPE | ||||||||||||
| C3 | 0.78 | 0.71 | 0.46 | 0.78 | 0.81 | 0.56 | C1 | C2 | C3 | ||||||||||
| C1 | BPF | 0.80 | 0.76 | 0.79 | 0.74 | 0.77 | 0.81 | 0.68 | 0.73 | 0.86 | |||||||||
| C2 | 0.82 | 0.81 | 0.82 | 0.76 | 0.90 | 0.79 | 0.70 | 0.72 | 0.83 | BPF | |||||||||
| C3 | 0.87 | 0.82 | 0.64 | 0.75 | 0.80 | 0.63 | 0.69 | 0.73 | 0.63 | C1 | C2 | C3 | |||||||
| C1 | BPG | 0.64 | 0.66 | 0.70 | 0.49 | 0.61 | 0.50 | 0.42 | 0.47 | 0.53 | # | 1.73 | 1.24 | ||||||
| C2 | 0.67 | 0.68 | 0.69 | 0.52 | 0.72 | 0.57 | 0.53 | 0.63 | 0.69 | 0.67 | 1.32 | 0.55 | BPG | ||||||
| C3 | 0.74 | 0.71 | 0.69 | 0.56 | 0.68 | 0.53 | 0.52 | 0.61 | 0.61 | 1.34 | 0.75 | 0.37 | C1 | C2 | C3 | ||||
| C1 | BPS | 0.54 | 0.67 | 0.71 | 0.46 | 0.45 | 0.42 | 0.48 | 0.46 | 0.51 | 0.11 | 0.22 | 0.41 | 0.70 | 0.60 | 0.55 | |||
| C2 | 0.36 | 0.44 | 0.40 | 0.75 | 0.67 | 0.64 | 0.52 | 0.63 | 0.67 | 0.09 | 0.12 | 0.39 | 0.62 | 0.53 | 0.58 | BPS | |||
| C3 | 0.55 | 0.58 | 0.35 | 0.73 | 0.71 | 0.47 | 0.75 | 0.74 | 0.56 | 0.08 | 0.12 | 0.17 | 0.99 | 0.76 | 0.58 | C1 | C2 | C3 | |
| C1 | BPFL | 1.03 | 1.33 | 0.9 | 0.73 | 0.64 | 0.71 | 1.00 | 0.87 | 0.88 | 0.21 | 0.42 | 0.84 | 0.93 | 0.65 | 0.70 | 0.35 | 0.85 | 0.68 |
| C2 | 0.77 | 0.79 | 0.79 | 0.54 | 0.6 | 0.68 | 0.72 | 0.77 | 0.83 | 0.04 | 0.17 | 0.31 | 0.48 | 0.53 | 0.59 | 0.29 | 0.48 | 0.74 | |
| C3 | 0.66 | 0.64 | 0.61 | 0.37 | 0.52 | 0.65 | 0.52 | 0.6 | 0.59 | 0.02 | 0.09 | 0.16 | 0.44 | 0.51 | 0.57 | 0.21 | 0.35 | 0.44 | |
MDR values for bisphenol A analogues binary mixtures toxicity studies performed with Microtox® assay (for IA modelling) (red—Synergism, blue—Antagonism, green—Overestimation, yellow—Underestimation, C1, C2 and C3 stand for 33, 66 and 100% of EC50 of respective analogue as presented in Table 1. #—data inconclusive).
|
| |||||||||||||||||||
| BPA | |||||||||||||||||||
| C1 | C2 | C3 | |||||||||||||||||
| C1 | BPC | 1.31 | 1.23 | 1.29 | |||||||||||||||
| C2 | 1.11 | 1.19 | 1.17 | BPC | |||||||||||||||
| C3 | 1.09 | 1.09 | 0.83 | C1 | C2 | C3 | |||||||||||||
| C1 | BPE | 1.58 | 1.44 | 1.32 | 1.07 | 1.27 | 1.10 | ||||||||||||
| C2 | 1.41 | 1.22 | 1.20 | 1.18 | 1.10 | 1.16 | BPE | ||||||||||||
| C3 | 1.26 | 1.40 | 0.76 | 1.14 | 0.89 | 0.80 | C1 | C2 | C3 | ||||||||||
| C1 | BPF | 1.22 | 1.18 | 1.19 | 1.24 | 1.20 | 1.10 | 1.14 | 1.16 | 1.10 | |||||||||
| C2 | 1.10 | 1.16 | 1.14 | 1.15 | 1.31 | 1.13 | 1.09 | 1.11 | 1.10 | BPF | |||||||||
| C3 | 1.09 | 1.14 | 0.88 | 1.14 | 1.11 | 0.87 | 1.15 | 1.13 | 0.86 | C1 | C2 | C3 | |||||||
| C1 | BPG | 1.13 | 1.01 | 1.04 | 0.95 | 0.91 | 0.95 | 0.87 | 0.95 | 0.96 | # | 1.61 | 3.40 | ||||||
| C2 | 1.00 | 0.96 | 0.97 | 1.28 | 1.06 | 0.98 | 0.90 | 0.95 | 0.95 | 2.50 | 2.80 | 1.72 | BPG | ||||||
| C3 | 0.98 | 0.92 | 0.91 | 0.87 | 0.83 | 0.77 | 0.94 | 0.94 | 0.86 | 1.64 | 1.17 | 0.87 | C1 | C2 | C3 | ||||
| C1 | BPS | 0.95 | 0.72 | 0.89 | 0.90 | 1.11 | 1.08 | 1.05 | 0.87 | 1.11 | 0.63 | 0.49 | 0.48 | 1.17 | 1.01 | 1.31 | |||
| C2 | 0.72 | 1.14 | 1.07 | 0.98 | 1.10 | 1.09 | 0.94 | 1.05 | 1.10 | 0.67 | 0.37 | 0.40 | 1.09 | 0.98 | 1.09 | BPS | |||
| C3 | 1.24 | 1.08 | 0.68 | 0.96 | 1.08 | 0.73 | 1.04 | 1.10 | 0.81 | 0.94 | 0.85 | 0.32 | 1.05 | 1.16 | 0.88 | C1 | C2 | C3 | |
| C1 | BPFL | 1.38 | 1.10 | 0.96 | 1.08 | 0.99 | 0.85 | 1.36 | 1.20 | 1.02 | 0.98 | 0.96 | 1.13 | 1.48 | 0.80 | 0.76 | 0.78 | 0.91 | 0.83 |
| C2 | 1.67 | 1.04 | 0.90 | 0.85 | 0.86 | 0.85 | 1.06 | 1.07 | 0.95 | 0.78 | 1.06 | 1.09 | 0.90 | 0.77 | 0.76 | 1.28 | 0.90 | 0.78 | |
| C3 | 1.08 | 0.98 | 0.80 | 0.89 | 0.86 | 0.88 | 1.03 | 1.07 | 0.85 | 1.19 | 0.99 | 0.87 | 0.91 | 0.80 | 0.79 | 0.85 | 1.05 | 0.70 | |